Tamoxifen is a selective estrogen receptor (ER) modulator, acting as an antagonist of ER action in breast tissue and breast cancer cells and is reported to be effective in the treatment of early breast cancer to prevent tumor growth. It has been shown to inhibit protein kinase C, PKC, and to activate autophagy by increasing intracellular ceramide levels.
